Case guide

UPDATED FEB 2026

Mesothelioma Clinical Trials

Part of the Asbestos / Mesothelioma investigation

The short answer

Clinical trials offer mesothelioma patients access to cutting-edge treatments — including CAR-T cell therapy, tumor-treating fields, novel checkpoint inhibitors, and gene therapy — not yet available as standard of care. Major mesothelioma centers run active trials and participation can improve survival while contributing to medical research.

People's Justice Research TeamUpdated February 20, 2026Fact-checked

Verified against court and regulatory records · No upfront fees · Your information is never sold

Free Case Review

Check your eligibility — free

Answer 2-3 quick questions to review your potential case.

Free · Confidential · About 2 minutes · A case specialist responds within 1 business day

Your answers are never sold or shared without your consent.

Current Promising Clinical Trials for Mesothelioma

Active areas of mesothelioma clinical research include: CAR-T cell therapy targeting mesothelin (MESO-CAR-T trials at Penn Medicine and NCI), which engineers the patient's own immune T-cells to recognize and kill mesothelioma cells expressing the mesothelin protein; tumor-treating fields (TTFields) using the Optune device, which delivers continuous low-intensity electric fields to disrupt cancer cell division — Phase III STELLAR trial showed median OS improvement; anti-mesothelin antibody-drug conjugates (anetumab ravtansine) combining tumor-targeting with direct cytotoxic payload delivery; and combination immunotherapy trials pairing existing checkpoint inhibitors with novel agents targeting TIM-3, LAG-3, and TIGIT immune checkpoints.

How to Find and Join a Clinical Trial

Patients can search for active mesothelioma clinical trials at ClinicalTrials.gov (National Institutes of Health trial registry) by searching for "mesothelioma" with filters for location, phase, and treatment type. Specialized mesothelioma centers running the highest volume of trials include: Memorial Sloan Kettering Cancer Center (New York), MD Anderson Cancer Center (Houston), Penn Medicine Abramson Cancer Center (Philadelphia), Brigham and Women's Hospital / Dana-Farber Cancer Institute (Boston), and University of Chicago Medicine. A mesothelioma specialist (thoracic oncologist) at these centers can evaluate trial eligibility and coordinate enrollment. Clinical trial participation does not affect legal claims — compensation from trust funds and lawsuits is fully available to patients regardless of trial enrollment.

Key data

Data & Statistics

2 SOURCED FIGURES

100+ active mesothelioma clinical trials open for enrollment as of 2026

ClinicalTrials.gov — NIH

STELLAR trial: TTFields + chemotherapy improved median OS by 2.2 months vs chemo alone

Journal of Clinical Oncology 2021

FAQ

Frequently Asked Questions

12 QUESTIONS

Mesothelioma is a cancer of the mesothelium — the thin membrane lining the lungs (pleura), abdomen (peritoneum), or heart (pericardium). It is distinct from lung cancer, which originates in the lung tissue itself. Mesothelioma is caused almost exclusively by asbestos exposure and does not arise from smoking. Lung cancer, while also caused by asbestos in some cases, is far more commonly caused by tobacco smoking. Both are compensable through asbestos trust funds and litigation, but mesothelioma claims typically produce higher compensation because the disease is more directly and singularly attributable to asbestos.

Dive deeper

Related Guides

19 GUIDES

The full investigation

Part of the Asbestos / Mesothelioma Investigation